<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41025408</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1550-9397</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine</Title><ISOAbbreviation>J Clin Sleep Med</ISOAbbreviation></Journal><ArticleTitle>Nocturnal cerebral oxygenation in patients with COPD at altitude: data from a randomized clinical trial of acetazolamide.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.5664/jcsm.11868</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVES" NlmCategory="OBJECTIVE">Patients with chronic obstructive pulmonary disease (COPD) may experience cerebral tissue deoxygenation during altitude travel, especially during sleep. We quantified nocturnal cerebral (CTO) and arterial oxygenation (SpO<sub>2</sub>) in patients with COPD during a stay at 3100 meters and evaluated the effects of preventive acetazolamide therapy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with moderate to severe COPD, living &lt; 800 meters, underwent nocturnal pulse oximetry and cerebral tissue oximetry by near-infrared spectroscopy at 760 meters and during the first night at 3100 meters. Patients were randomized to 375 mg/day acetazolamide or placebo starting 24 hours before ascent and while staying at 3100 meters. Altitude and acetazolamide effects on CTO and other outcomes were evaluated by mixed linear regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Forty-three patients, 9 female, mean&#xb1;SD age 55.4&#xb1;8.9 years, FEV<sub>1</sub> 60&#xb1;13% predicted, were included in the analysis. When ascending from 760 to 3100 meters taking placebo (N=17), CTO and SpO<sub>2</sub> decreased from 66.5&#xb1;1.0% to 63.4&#xb1;1.0% (P&lt;0.05) and from 90.8&#xb1;0.4% to 83.7&#xb1;0.4% (P&lt;0.05), respectively; cerebral (cODI) and arterial (aODI) oxygen desaturation indices (&#x2265;4% dips in CTO or SpO<sub>2</sub>, respectively) increased by a mean(95%CI) of 6.2/h (4.0 to 8.5) and 19.5/h (13.2 to 25.9); (P&lt;0.05). Compared to placebo, the mean CTO (+2.3% [2.2 to 2.5]) and SpO<sub>2</sub> (+2.1% [2.1 to 2.2]) were higher and the mean cODI (-4.4/h [-7.3 to -1.5]) and aODI (-15.0/h [-23.1 to -6.9]) were lower in the acetazolamide group, P&lt;0.05 all effects.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patients with COPD travelling to 3100 meters experienced sustained and intermittent nocturnal cerebral deoxygenation related to hypoxemia. Acetazolamide mitigated these altitude-related deoxygenations, albeit not to lowland values.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">Registry: ClinicalTrials.gov; Identifier: NCT03156231.</AbstractText><CopyrightInformation>&#xa9; 2025 American Academy of Sleep Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmuziger</LastName><ForeName>Ya&#xeb;l A</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mademilov</LastName><ForeName>Maamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Center for Cardiology and Internal Medicine, Department of Respiratory Medicine, Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buergin</LastName><ForeName>Aline</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheiwiller</LastName><ForeName>Philipp M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Simon R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtblau</LastName><ForeName>Mona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bitos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muralt</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akylbekov</LastName><ForeName>Azamat</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center for Cardiology and Internal Medicine, Department of Respiratory Medicine, Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirzalieva</LastName><ForeName>Gulzada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National Center for Cardiology and Internal Medicine, Department of Respiratory Medicine, Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sooronbaev</LastName><ForeName>Talant M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>National Center for Cardiology and Internal Medicine, Department of Respiratory Medicine, Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulrich</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>Konrad E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furian</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital of Zurich, Department of Respiratory Medicine, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss-Kyrgyz High Altitude Medicine and Research Initiative, Zurich, Switzerland, and Bishkek, Kyrgyz Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Swiss University of Traditional Chinese Medicine, Research Department, Bad Zurzach, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03156231</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Sleep Med</MedlineTA><NlmUniqueID>101231977</NlmUniqueID><ISSNLinking>1550-9389</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">hypobaric hypoxia</Keyword><Keyword MajorTopicYN="N">near-infrared spectroscopy</Keyword><Keyword MajorTopicYN="N">respiratory polygraphy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41025408</ArticleId><ArticleId IdType="doi">10.5664/jcsm.11868</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>